Ethinylestriol
![]() | |
Clinical data | |
---|---|
Other names | EE3; 17α-Ethynylestriol; 17α-Ethynylestra-1,3,5(10)-triene-3,16α,17β-triol |
Routes of administration | By mouth |
Drug class | Estrogen |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
ChEMBL |
|
Chemical and physical data | |
Formula | C20H24O3 |
Molar mass | 312.409 g·mol−1 |
3D model (JSmol) |
|
| |
InChI
|
Ethinylestriol (EE3), or 17α-ethynylestriol, also known as 17α-ethynylestra-1,3,5(10)-triene-3,16α,17β-triol, is a synthetic estrogen which was never marketed.[1] Nilestriol, the 3-cyclopentyl ether of ethinylestriol, is a prodrug of ethinylestriol, and is a more potent estrogen in comparison,[1] but, in contrast to ethinylestriol, has been marketed.[2] Ethinylestriol has been found to reduce the risk of 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary cancer when given as a prophylactic in animal models, while other estrogens like ethinylestradiol and diethylstilbestrol were ineffective.[3]
See also
References
- ^ a b McGuire W (14 December 2013). Experimental Biology. Springer Science & Business Media. pp. 161–. ISBN 978-1-4757-4673-0.
- ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 891–. ISBN 978-1-4757-2085-3.
- ^ Lemon HM (December 1987). "Antimammary carcinogenic activity of 17-alpha-ethinyl estriol". Cancer. 60 (12): 2873–81. doi:10.1002/1097-0142(19871215)60:12<2873::AID-CNCR2820601204>3.0.CO;2-B. PMID 3119187.
- v
- t
- e
Agonists |
|
---|---|
Antagonists | |
Unknown |
- See also
- Receptor/signaling modulators
- Estrogens and antiestrogens
- Androgen receptor modulators
- Progesterone receptor modulators
- List of estrogens
![]() | This article about a steroid is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
![]() | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e